{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:09:03Z","timestamp":1789708143432,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004006","name":"Istanbul University Scientific Research Projects Unit","doi-asserted-by":"publisher","award":["TDP-2020-36598"],"award-info":[{"award-number":["TDP-2020-36598"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bioorg.2025.108203","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T13:01:20Z","timestamp":1737637280000},"page":"108203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["New 2-indolinone-indole hybrid compounds carrying a benzoyl moiety as tyrosine kinase inhibitors"],"prefix":"10.1016","volume":"156","author":[{"given":"Merve","family":"Camc\u0131-Eren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu\u011f\u00e7e","family":"Cinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6k\u00e7e","family":"Cihan-\u00dcst\u00fcnda\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcne\u015f","family":"\u00d6zen-Ero\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6yk\u00fcm","family":"Gen\u00e7-Akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Erol-Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Sancar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00fcsun","family":"\u00d6ztay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"Soylu-Eter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eehnaz","family":"Bolkent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Kuruca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilg\u00fcn","family":"Karal\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108203_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105165","article-title":"Design, Hemiysnthesis, crystal structure and anticancer activity of 1, 2, 3-triazoles derivatives of totarol","volume":"115","author":"Laamari","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108203_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105884","article-title":"Novel azine linked hybrids of 2-indolinone and thiazolodinone scaffolds as CDK2 inhibitors with potential anticancer activity: in silico design, synthesis, biological, molecular dynamics and binding free energy studies","volume":"126","author":"Qayed","year":"2022","journal-title":"Bioorg. Chem"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108203_b0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.21037\/jtd.2017.02.75","article-title":"Cancer prevention from the perspective of global cancer burden patterns","volume":"9","author":"Nagai","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108203_b0020","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","article-title":"Current challenges in cancer treatment","volume":"38","author":"Zugazagoitia","year":"2016","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bioorg.2025.108203_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111700","article-title":"1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships","volume":"183","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108203_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112752","article-title":"Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity","volume":"208","author":"Mahmoud","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108203_b0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bioorg.2019.01.016","article-title":"Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers","volume":"85","author":"El-Sharief","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"40","key":"10.1016\/j.bioorg.2025.108203_b0040","doi-asserted-by":"crossref","first-page":"23522","DOI":"10.1039\/D0RA02525A","article-title":"Regio- and diastereoselective synthesis of spiropyrroloquinoxaline grafted indole heterocyclic hybrids and evaluation of their anti-Mycobacterium tuberculosis activity","volume":"10","author":"Arumugam","year":"2020","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108203_b0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41392-022-01168-8","article-title":"Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective","volume":"7","author":"Yang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"24","key":"10.1016\/j.bioorg.2025.108203_b0050","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1038\/s41388-021-01841-2","article-title":"Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches","volume":"40","author":"Saraon","year":"2021","journal-title":"Oncogene"},{"issue":"22","key":"10.1016\/j.bioorg.2025.108203_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228529","article-title":"Tyrosine kinase receptors in oncology","volume":"21","author":"Esteban-Villarrubia","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108203_b0060","unstructured":"R. Roskoski, Protein kinase inhibitors. [cited 2024 29.11.2024]; Available from: https:\/\/brimr.org\/protein-kinase-inhibitors\/."},{"key":"10.1016\/j.bioorg.2025.108203_b0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semcancer.2018.09.011","article-title":"Small molecule tyrosine kinase inhibitors and pancreatic cancer-Trials and troubles","volume":"56","author":"Lakkakula","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2025.108203_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102466","article-title":"Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer","volume":"110","author":"Iyer","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bioorg.2025.108203_b0075","doi-asserted-by":"crossref","unstructured":"H.A.A. Abd El-Wahab et al., New cell cycle checkpoint pathways regulators with 2-Oxo-indoline scaffold as potential anticancer agents: Design, synthesis, biological activities and in silico studies, Bioorg. Chem. 120 (2022) 105622. Doi: 10.1016\/j.bioorg.2022.105622 From NLM Medline.","DOI":"10.1016\/j.bioorg.2022.105622"},{"key":"10.1016\/j.bioorg.2025.108203_b0080","series-title":"Pharmaceutical Chemistry","article-title":"Oksindol T\u00fcrevi Baz\u0131 Yeni Bile\u015fiklerin Sentezleri ve AntiKanserojen Aktivitelerinin Ara\u015ft\u0131r\u0131lmas\u0131","author":"K\u0131l\u0131\u00e7-Kurt","year":"2014"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108203_b0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/138955712798995039","article-title":"Indolinones as promising scaffold as kinase inhibitors: a review","volume":"12","author":"Prakash","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108203_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129283","article-title":"3-Arylidene-2-oxindoles as GSK3\u03b2 inhibitors and anti-thrombotic agents","volume":"87","author":"Babkov","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108203_b0095","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1080\/14756366.2022.2085693","article-title":"Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies","volume":"37","author":"Taghour","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108203_b0100","first-page":"99","article-title":"SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1\/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types","volume":"59","author":"Fong","year":"1999","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108203_b0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tiv.2005.06.047","article-title":"Distribution, metabolism, and excretion of the anti-angiogenic compound SU5416","volume":"20","author":"Ye","year":"2006","journal-title":"Toxicol. In Vitro"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108203_b0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00280-006-0376-5","article-title":"Sunitinib malate","volume":"60","author":"Izzedine","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108203_b0115","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1634\/theoncologist.2012-0044","article-title":"FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors","volume":"17","author":"Blumenthal","year":"2012","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108203_b0120","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/tcrm.2007.3.2.341","article-title":"Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)","volume":"3","author":"Le Tourneau","year":"2007","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108203_b0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1593\/neo.06673","article-title":"Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line","volume":"9","author":"Ackerstaff","year":"2007","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108203_b0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s004320000196","article-title":"Effect of the nonsteroidal anti-inflammatory drug indomethacin on proliferation and apoptosis of colon carcinoma cells","volume":"127","author":"Kralj","year":"2001","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108203_b0135","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/sj.bjc.6604010","article-title":"Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1","volume":"97","author":"de Groot","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108203_b0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.20883\/medical.e43","article-title":"Abrief history of taxol","volume":"83","author":"\u017bwawiak","year":"2014","journal-title":"J. Med. Sci."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108203_b0145","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.ejmech.2010.08.004","article-title":"Synthesis and evaluation of indole, pyrazole, chromone and pyrimidine based conjugates for tumor growth inhibitory activities\u2013development of highly efficacious cytotoxic agents","volume":"45","author":"Singh","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108203_b0150","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejmech.2014.04.004","article-title":"Substituted E-3-(3-indolylmethylene)1,3-dihydroindol-2-ones with antiproliferative activity. Study of the effects on HL-60 leukemia cells","volume":"79","author":"Leoni","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108203_b0155","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.bmc.2003.11.031","article-title":"Substituted E-3-(2-Chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity","volume":"12","author":"Andreani","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"01","key":"10.1016\/j.bioorg.2025.108203_b0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4236\/pp.2012.31010","article-title":"Indolin-2-ones in clinical trials as potential kinase inhibitors: a review","volume":"03","author":"Prakash","year":"2012","journal-title":"Pharmacol. Pharm."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108203_b0165","doi-asserted-by":"crossref","first-page":"9018","DOI":"10.1128\/MCB.20.23.9018-9027.2000","article-title":"SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling","volume":"20","author":"Blake","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2025.108203_b0170","unstructured":"N. Karal\u0131, G. Cihan-\u00dcst\u00fcnda\u011f, New 3-arylidene-2-indolinone derivatives, 2020."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108203_b0175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/toxsci\/kfh248","article-title":"Inflammatory cytokines and cell death in BEAS-2B lung cells treated with soil dust, lipopolysaccharide, and surface-modified particles","volume":"82","author":"Veranth","year":"2004","journal-title":"Toxicol. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108203_b0180","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ijc.2910500624","article-title":"Regulation of human colon-carcinoma cell adhesion to extracellular matrix by transforming growth factor beta 1","volume":"50","author":"Chakrabarty","year":"1992","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108203_b0185","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3892\/ijmm.2015.2164","article-title":"Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro","volume":"35","author":"Yamaguchi","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108203_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/nu10081021","article-title":"Anti-cancer natural products and their bioactive compounds inducing ER stress-mediated apoptosis: a review","volume":"10","author":"Kim","year":"2018","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108203_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106225","article-title":"c-Src binds to the cancer drug Ruxolitinib with an active conformation","volume":"9","author":"Duan","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108203_b0200","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.bmc.2013.01.047","article-title":"Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure-activity relationship analysis","volume":"21","author":"Zhong","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108203_b0205","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ultsonch.2011.03.023","article-title":"Ultrasound promoted clay catalyzed efficient and one pot synthesis of substituted oxindoles","volume":"18","author":"Dandia","year":"2011","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.bioorg.2025.108203_b0210","unstructured":"S. Chang, S.Y. Hong, Y.S. Park, Y. Hwang, Y.B. Kim, Method for producing lactam compound, and lactam compound produced thereby, 2020."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108203_b0215","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ejmech.2007.05.012","article-title":"Synthesis and antiproliferative activities of isoindigo and azaisoindigo derivatives","volume":"43","author":"Bouchikhi","year":"2008","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108203_b0220","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/ejoc.201701807","article-title":"Synthesis of 2\u2010Oxindoles from Substituted Indoles by Hypervalent\u2010Iodine Oxidation","volume":"2018","author":"Jiang","year":"2018","journal-title":"Eur. J. Org. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108203_b0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.24820\/ark.5550190.p011.766","article-title":"A new synthetic approach to oxindoles (1,3-dihydro-<i>2H<\/i>-indol-2-ones) by reductive dephosphorylation with hydroiodic acid of 3-(diethylphosphoryloxy)- oxindoles, derived from isatins (1<i>H<\/i>-Indole-2,3-diones)","volume":"2022","author":"Liu","year":"2022","journal-title":"ARKIVOC"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108203_b0230","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.bmc.2010.01.011","article-title":"Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors","volume":"18","author":"Mologni","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108203_b0235","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/cber.19691020430","article-title":"Zur Chemie des Indols, VI. \u03b1.\u03b2\u2032\u2010Diindolylmethane und \u2010methene. Der Urorosein\u2010Chromophor","volume":"102","author":"von Dobeneck","year":"2006","journal-title":"Chem. Ber."},{"key":"10.1016\/j.bioorg.2025.108203_b0240","article-title":"Novel therapeutic use of indolinone derivatives","author":"Bouerat","year":"2005","journal-title":"L. Pharma, Editor."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108203_b0245","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1021\/jm400311n","article-title":"Synthesis, in vitro, and in cell studies of a new series of [indoline-3,2'-thiazolidine]-based p53 modulators","volume":"56","author":"Bertamino","year":"2013","journal-title":"J. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2025.108203_b0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2025.108203_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105723","article-title":"Vitamin D modulates E-cadherin turnover by regulating TGF-beta and Wnt signalings during EMT-mediated myofibroblast differentiation in A459 cells","volume":"202","author":"Sari","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.108203_b0260","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108203_b0265","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/jcb.29920","article-title":"Effect of long noncoding RNAs on epithelial-mesenchymal transition in A549 cells and fibrotic human lungs","volume":"122","author":"Yildirim","year":"2021","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2025.108203_b0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-60327-017-5_2","article-title":"Flow cytometry-based apoptosis detection","volume":"559","author":"Wlodkowic","year":"2009","journal-title":"Methods Mol. Biol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T01:56:21Z","timestamp":1758851781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825000835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":54,"alternative-id":["S0045206825000835"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108203","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New 2-indolinone-indole hybrid compounds carrying a benzoyl moiety as tyrosine kinase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108203"}}